Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRI) Profit After Tax: 2020-2025

Historic Profit After Tax for Biofrontera (BFRI) over the last 5 years, with Sep 2025 value amounting to -$6.6 million.

  • Biofrontera's Profit After Tax fell 17.29% to -$6.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$17.6 million, marking a year-over-year decrease of 36.89%. This contributed to the annual value of -$17.8 million for FY2024, which is 11.78% up from last year.
  • Biofrontera's Profit After Tax amounted to -$6.6 million in Q3 2025, which was down 24.89% from -$5.3 million recorded in Q2 2025.
  • Over the past 5 years, Biofrontera's Profit After Tax peaked at $5.6 million during Q1 2022, and registered a low of -$16.0 million during Q3 2021.
  • For the 3-year period, Biofrontera's Profit After Tax averaged around -$4.9 million, with its median value being -$5.7 million (2024).
  • In the last 5 years, Biofrontera's Profit After Tax spiked by 257.36% in 2022 and then plummeted by 1,971.60% in 2025.
  • Over the past 5 years, Biofrontera's Profit After Tax (Quarterly) stood at -$14.5 million in 2021, then spiked by 80.80% to -$2.8 million in 2022, then soared by 226.61% to $3.5 million in 2023, then tumbled by 139.59% to -$1.4 million in 2024, then declined by 17.29% to -$6.6 million in 2025.
  • Its last three reported values are -$6.6 million in Q3 2025, -$5.3 million for Q2 2025, and -$4.2 million during Q1 2025.